Dr Sara Prickett
immunology
Aravax
New Zealand
Biography
Co-Founder, Chief Operations Officer Sara Prickett has over 15 years’ research experience in cellular immunology and was responsible for the preclinical development of Aravax's peanut allergy therapy. Prior to Aravax, Dr Prickett held senior research posts within Alfred Health and Monash University. Dr Prickett received her Bachelor of Science from Sheffield University and PhD from Imperial College, London.
Research Interest
cellular immunology
